-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BV23QSCiZ2Z4PnjYbD2XRD0U2sm92rSlV2fs17YzKmVOv7pfR/Z/JUOGuatJ8ltx esY2Juqpnr2+nG6S47i7ag== 0000950134-01-504200.txt : 20010720 0000950134-01-504200.hdr.sgml : 20010720 ACCESSION NUMBER: 0000950134-01-504200 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20010719 ITEM INFORMATION: ITEM INFORMATION: FILED AS OF DATE: 20010719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMEDISYS INC CENTRAL INDEX KEY: 0000896262 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 113131700 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-24260 FILM NUMBER: 1684707 BUSINESS ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 BUSINESS PHONE: 2252922031 MAIL ADDRESS: STREET 1: 11100 MEAD ROAD STE 300 CITY: BATON ROUGE STATE: LA ZIP: 70816 FORMER COMPANY: FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP DATE OF NAME CHANGE: 19940819 FORMER COMPANY: FORMER CONFORMED NAME: M&N CAPITAL CORP DATE OF NAME CHANGE: 19930125 8-K 1 d89176e8-k.txt FORM 8-K 1 U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K - -------------------------------------------------------------------------------- CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of Earliest Event Reported): July 19, 2001 AMEDISYS, INC. -------------- (Exact Name of Registrant as Specified in Charter) Delaware -------- (State or Other Jurisdiction of Incorporation or Organization) 0-24260 11-3131700 -------- ---------- (Commission File Number) (I.R.S. Employer Identification No.) 11100 Mead Road, Suite 300, Baton Rouge, LA 70816 ------------------------------------------------- (Address of principal executive offices including zip code) (225) 292-2031 -------------- (Registrant's telephone number, including area code) 2 ITEM 5. OTHER EVENTS On July 19, 2001, Amedisys, Inc., "the Company", issued a press release attached hereto as Exhibit 99.1 to announce expected second quarter earnings. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (a) Financial Statements of Business Acquired. Not applicable. (b) Pro Forma Financial Information. Not applicable. (c) Exhibit No. Page ------- ---- 99.1(i) Press Release dated July 19, 2001 to announce expected second quarter earnings................ A-1 (i) Filed herewith. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AMEDISYS, INC. By: /s/ John M. Joffrion ---------------------------------------- John M. Joffrion Senior Vice President of Finance Principal Accounting and Financial Officer DATE: July 19, 2001 3 EXHIBIT INDEX
(c) Exhibit No. Page ------- ---- 99.1(i) Press Release dated July 19, 2001 to announce expected second quarter earnings................................. A-1
(i) Filed herewith. EX-99.1 2 d89176ex99-1.txt PRESS RELEASE DATED JULY 19, 2001 1 For Immediate Release Exhibit 99.1 - --------------------- ------------ AMEDISYS EXPECTS SECOND QUARTER EARNINGS TO APPROXIMATE $1 MILLION BATON ROUGE, Louisiana (July 19, 2001) - Amedisys, Inc. (OTC BB: "AMED") hosted a conference call on July 18, 2001 to discuss with investors the financial impact of a previously announced overstatement in net service revenue for the quarters ended December 31, 2000 and March 31, 2001. During the conference call, the Company made certain forward-looking statements with respect to projected earnings which are described herein. For the quarter ending June 30, 2001, the Company expects to report pretax net income of approximately $1 million. The expected improvement in profitability, from the first quarter of 2001 to the second quarter of 2001, primarily reflects the anticipated impact of a Medicare price increase resulting from the Benefits Improvement and Protection Act of 2000, which became effective April 1, 2001. "I want to thank the investing community for their patience and support as we have undertaken an extensive review of our systems during the past several weeks," stated William F. Borne, Chairman and Chief Executive Officer of Amedisys, Inc. "Our commitment to provide quality patient care and increase shareholder value remains unchanged, and we look forward to the opportunities that our future holds." A REPLAY OF THE CONFERENCE CALL WILL BE AVAILABLE THROUGH JULY 25, 2001, BY DIALING 800-428-6051. THE ACCESS CODE IS #202030 FOR THE REPLAY. Amedisys, Inc. is a multi-regional provider of home health nursing services and is headquartered in Baton Rouge, Louisiana. Its common stock trades on the OTC Bulletin Board under the symbol "AMED". This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in government reimbursement procedures, dependence upon third-party vendors, and other risks discussed in the Company's periodic filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release. Additional information on this Company can be found on the World Wide Web http://www.amedisys.com For further information, please contact: John Joffrion, Senior Vice President at (225) 292-2031 or RJ Falkner & Company, Inc., Investor Relations Counsel at (800) 377-9893 or via e-mail at info@rjfalkner.com -----END PRIVACY-ENHANCED MESSAGE-----